Billionaire Profile
Randal J. Kirk
Global Rank
#2308

Image: Public domain | via Wikimedia Commons

Randal J. Kirk

CEO, Precigen
US
Real-Time Net Worth
$1.6B
As of December 2025
Age
71
Source
Pharmaceuticals
Industry
healthcare
Citizenship
US

Biography

Randal J. Kirk, a 71-year-old US citizen, is a prominent figure in the healthcare industry. He is recognized for his success in the pharmaceuticals sector, with an estimated net worth of $1.6 billion. Kirk's career includes founding multiple companies, notably selling New River Pharmaceuticals for $2.6 billion in 2007, and Clinical Data for $1.2 billion in 2011. His wealth source is primarily pharmaceuticals, and he is also involved with Third Security, a life-sciences investment firm, which he founded in 1999.

Wealth Over Time

In-Depth Profile

Early Life and Education

Randal J. Kirk was born on March 1, 1954, in Pleasanton, California. His family later moved to Texas and Virginia. He graduated from Pulaski High School and then worked selling cars and motorcycles while studying part-time at Radford University, where he earned a bachelor's degree in Economics in 1976. He then pursued a Juris Doctor at the University of Virginia in 1979.

Rise to Success

Kirk's career began as an attorney after being admitted to the bar in 1980, becoming the only attorney in Bland, Virginia. In 1983, he co-founded General Injectables and Vaccines, which was sold for $65 million in 1998. His entrepreneurial ventures continued with New River Pharmaceuticals, founded in 1996, which he took public in 2004 and sold to Shire in 2007 for $2.6 billion, earning over $1 billion personally. Following these successes, Kirk established the life-sciences investment firm Third Security, LLC in 1999.

Key Business Strategies

Kirk's business strategy often involves identifying promising biotech companies early and investing significantly. He is known for his ability to recognize and capitalize on opportunities in the pharmaceutical and biotechnology sectors. His approach includes taking significant stakes in smaller companies and staying involved until products reach the market, as seen with New River Pharmaceuticals. He has also been involved in several companies that advocate for genetic engineering projects.

Philanthropy

Randal J. Kirk has made charitable contributions, including a $1 million donation to Radford University to establish the Zylphia Shu-En Kirk Endowment. He has also served on the boards of the Radford University Foundation and the University of Virginia.

Career Milestones

1980

Admitted to the Bar

Became the only attorney in Bland, Virginia.

1983

Co-founded General Injectables and Vaccines

Co-founded the company with John Gregory.

1996

Founded New River Pharmaceuticals

Founded New River Pharmaceuticals.

1999

Founded Third Security, LLC

Established the life-sciences investment firm.

2007

Sold New River Pharmaceuticals to Shire

Sold New River Pharmaceuticals for $2.6 billion.

2008

Chairman of Intrexon's board

Became chairman of Intrexon's board

2020

Stepped down as CEO of Precigen

Stepped down as CEO of Precigen

Philanthropy & Social Impact

Education

Zylphia Shu-En Kirk Endowment

$1M

Established at Radford University.